Delivery Order SPE2DB20D3101-SPE2DB24FRVS0

Award Date 9/20/24
Potential Completion Date 9/23/24
Potential Value $3.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,604.96 firm fixed-price contract is for the delivery of 4558761087 LIDOCAINE HCL 2% VIAL 5ML. The award has an ultimate completion date of October 14, 2022. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $3,079.70 and a performance period ending on January 13, 2025. The contract is for the delivery of LIDOCAINE HCL 2% 200 MG/10 ML 10ML, a medical supply item. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,808.14, is for the delivery of 4566422986 - LIDOCAINE 2% VISCOUS SOLN 100ML, with a completion date of November 14, 2024. The contract is a Delivery Order under a Firm Fixed Price arrangement, with no set-aside designation indicated. Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,647.10, is a Firm Fixed Price Delivery Order for the supply of LIDOCAINE HCL 1% 50 MG/5 ML VL 5ML, a pharmaceutical product. The contract has an ultimate completion date of May 31, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...
This federal contract award was made to Amerisourcebergen Drug Corp, Corporate Office division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract, valued at $1,533.00, is a Delivery Order with a Firm Fixed Price awarded by the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD). The contract is for the delivery of 4564381288 - LIDOCAINE HCL 2% VIAL 5ML, with a performance period ending on April 25, 2024. This award is...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of LIDOCAINE HCL 2% 200 MG/10 ML 10ML. The contract has a firm fixed price of $4,135.18 and a completion date of December 24, 2024. The award is not designated as a set-aside contract. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $2,003.52, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567497375 ! LIDOCAINE HCL 1% VIAL 50ML, with a completion date of March 10, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
This federal contract award, valued at $1,360.40, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of 4567385393 ! LIDOCAINE HCL 2% 200 MG/10 ML 10ML, a medical supply item. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of February 27, 2025. The award was issued on February 26, 2025, and there was no set-aside designation....
This federal contract award, valued at $2,997.52, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA, which is valued at $999,999,999 and runs through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...
This is a delivery order contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $3,888.91 firm fixed-price contract is for the supply of 4563714161 LIDOCAINE HCL 2% 200 MG/10 ML 10ML, a medical product. The contract has a period of performance through February 21, 2024. AmerisourceBergen is an experienced federal contractor that holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical for a...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB24FRVS0
    Delivery Order

This federal contract award to AmerisourceBergen Drug Corp (AmerisourceBergen) is for the delivery of 4565892411 - LIDOCAINE HCL 2% 200 MG/10 ML 10ML. The award, valued at $3,614.49, was issued by the Defense Logistics Agency (DLA) on September 20, 2024, with a completion date of September 23, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type.

AmerisourceBergen is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Additionally, AmerisourceBergen maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

The contract award does not have a set-aside designation, indicating open competition.

Generated 1/24/25, 9:19 AM